In conclusion, although several studies proposed Nrf2 and HO-1 inhibition as a possible strategy to sensitize resistant glioma cells to chemotherapy, the above-mentioned studies demonstrated a non- univocal role of HO-1 expression. The gene discussed is HMOX1; the disease is central nervous system cancer.